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Abstract. In low energy brachytherapy, the presence of tissue heterogeneities
contributes significantly to the discrepancies observed between treatment plan and
delivered dose. In this work, we present a simplified analytical dose calculation
algorithm for heterogeneous tissue. We compare it with Monte Carlo computations
and assess its suitability for integration in clinical treatment planning systems. The
algorithm, named as RayStretch, is based on the classic equivalent path length
method and TG-43 reference data. Analytical and Monte Carlo dose calculations
using Penelope2008 are compared for a benchmark case: a prostate patient with
calcifications. The results show a remarkable agreement between simulation and
algorithm, the latter having in addition a high calculation speed. The proposed
analytical model is compatible with clinical real-time treatment planning systems
based on TG-43 consensus datasets for improving dose calculation and treatment
quality in heterogeneous tissue. Moreover, the algorithm is applicable for any type
of heterogeneities.
PACS numbers: 87.53.Jw, 87.55.K, 87.53.Kn, 87.55.-x, 87.55.Gh, 87.53.Bn, 87.19.X-,
87.59.bd
Keywords: brachytherapy, low dose rate, heterogeneities, prostate, calcifications.
Phys. Med. Biol. 2
1. Introduction
Nowadays, Brachytherapy (BT) is a very important weapon in any oncologist arsenal
to manage certain types of cancer. The most usual locations where BT is used are
gynaecological, skin, breast, and prostate malignancies. Together with improvements
in trans-rectal ultrasound (US) image guidance, permanent low energy (LE) seed
implantation has become one of the most successful approaches for treatment of early
stage prostate carcinoma (Yu et al. 1999, Pfeiffer et al. 2008).
Current BT treatment planning systems (TPS) allow direct introduction of
tabulated dose rates from the literature using the Task Group 43 (TG-43)
formalism (Rivard et al. 2007). Consensus datasets for all commercially available
photon sources can be found in the joint American Association of Physicists in Medicine
(AAPM) and European Society for Radiotherapy and Oncology (ESTRO) reports
for high energy (HE) (Perez-Calatayud et al. 2012), and in the AAPM Low Energy
Brachytherapy working group supplement to TG-43 (Rivard et al. 2007) for LE. One of
the main assumptions behind the TG-43 formalism is the choice of and unbounded water
volume as the reference dosimetry medium. This works flawlessly in water-equivalent
materials, however it has become evident nowadays that there are certain regions where
such approximation might break down.
The reason for such issues can be traced back to fundamental physics considerations
simply by focusing on the energy range where the different sources are classified. For LE
sources, the photon interaction with matter is mainly dominated by the photoelectric
interaction. Such interaction has a strong dependence on the atomic number (Z), and
hence on tissue composition. For a HE source, the interaction is governed by Compton
scattering; however, the photoelectric interaction might still play a role for high−Z
materials, i.e. for shielding considerations. Thus, the implicit all-water approximation
for dose calculations using TG-43 formalism is much poorer at low and intermediate
energies than at high energies (E > 200 keV) (Beaulieu et al. 2012).
Of particular importance is the case of the prostate, where calcifications
(accumulation of calcium within a tissue) may appear. Such prostate calculi are rather
infrequent below the age of 40 years, however they are common in males over 50
years. They may be solitary but usually occur in clusters located in the posterior and
lateral lobes. They are most often asymptomatic, therefore no information regarding
its existence is available before imaging the patient. They constitute the main source of
heterogeneities found in prostate, both in density and composition. Therefore, LE seed
implantation using water-based TG-43 dose distributions might be inaccurate in their
vicinity.
Nowadays, the recommended technique (GEC-ESTRO (Salembier et al. 2007), TG-
137 (Nath et al. 2009), ABS 2012 (Davis et al. 2012)) for prostate implants is an intra-
operative procedure using trans-rectal US images. An optimum dose distribution of the
implant is obtained by inverse planning techniques using TG-43 data. The outcome of
this planning is the number and position of seeds in the prostate. In clinical practice, a
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month later, a dosimetric reassessment of the implant using magnetic resonance (MRI)
or computerized tomography (CT) images (the so called post-plan) is performed based
on the TPS algorithm. Its aim is to check the positions of the seeds and dosimetry once
the oedema has reduced.
In some exceptional cases (not in clinical routine), research groups perform Monte
Carlo (MC) simulations based on the post-plan to account for heterogeneities present
in the prostate. This effort documents the actual treatment, but there is no possibility
to intervene based on its outcome. Hence, the calculations derived from MC in LE
brachytherapy do not transfer into a direct benefit to the patient in terms of an optimal
plan, however focus exclusively on the accurate knowledge of the dose distribution in
an implant already done.
In (Chibani and Williamson 2005), an accelerated MC code was developed for
dose calculation in prostate BT. Dosimetric effects of inter-seed attenuation, tissue
composition, and tissue calcifications were analysed. The effect caused by the presence
of calcifications covering 1% − 5% of the prostate volume was discussed. It was found
to decrease D80, D90, and D100 values (meaning the minimum dose covering 80%, 90%
and 100% of the volume) by up to 32%, 37%, and 58% respectively.
A study was performed in (Landry et al. 2010) to assess the sensitivity of MC dose
calculations to uncertainties in human tissue composition for LE BT and electronic
sources. They concluded that LE brachytherapy dose distributions in tissue differ from
water and are influenced by density, mean tissue composition, and patient-to-patient
composition variations. The results support the use of a dose calculation algorithm
accounting for heterogeneities such as MC.
The impact of tissue heterogeneities in breast tissue was addressed in (Afsharpour
et al. 2010). The impact of tissue heterogeneity and inter-seed attenuation was studied
in post-implant evaluation of five clinical permanent breast 103Pd seed implants by
means of MC simulations. The authors concluded that the average planning target
volume D90 reduction varies from 3.9% to 35.5% depending on breast tissue composition.
Furthermore, the skin D10 increases by 28.2% in an entirely adipose breast.
A similar issue was addressed in (Afsharpour et al. 2011). Six modelling schemes
including uniform and non-uniform water breast, uniform and non-uniform glandular
and adipose mixed tissues, and age-dependent breast, were discussed. The high
sensitivity of dosimetry on the modelling scheme reported by the authors argues in
favour of an agreement on a standard tissue modelling approach to be used in LE breast
brachytherapy.
(Landry et al. 2011) compared Dm,m, where the radiation is transported in the
medium and the dose is scored in the same medium, and Dw,m, where the radiation
is transported in the medium but the dose is scored in water, obtained from MC
simulations for a selection of human tissues of interest using LE low dose rate (LDR)
and electronic brachytherapy sources. Large differences were observed between both
scoring schemes for a variety of tissues. The authors concluded underlining the need for
guidelines on choice of media for dose reporting.
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In (Ghorbani et al. 2014), the effect of tissue composition on dose distribution for
different tissues was discussed for 103Pd, 125I, 169Yb, and 192Ir sources. They concluded
that TPS considering only a homogeneous treatment volume create errors in dose
calculations, the deviation depending on the type of soft tissue, BT source, as well
as the distance to the source.
Once the significant impact of heterogeneities and tissue composition is proven,
the necessity of complete and detailed dosimetry calculations beyond TG-43 formalism
and supported by CT (and MRI) image techniques arises inevitably. The AAPM
established a task group (TG-186) to provide guidance for early adopters of model-
based dose calculations algorithms (MBDCAs) for BT to ensure practice uniformity.
Such group published a comprehensive report on 2012 (Beaulieu et al. 2012). In
some scenarios, dosimetric discrepancies between MBDCAs and water-based TG-43
approaches can reach up to one order of magnitude. Thus, serious concerns were raised
and recommendations for a new commissioning procedure of MBDCAs were established.
In summary, in the context of LE BT, the presence of tissue heterogeneities
may contribute significantly to dosimetric discrepancies between treatment plan and
delivered dose, and several groups are taking efforts to overcome these deviations.
The aim of this paper is to present an analytical algorithm for tissue heterogeneities
that could complement the TG-43 formalism used in commercial TPS. As a proof-of-
concept, we study the case of a single seed in a prostate with calcifications (according
to an actual patient CT).
2. Materials and methods
2.1. Phantom model
To analyse the influence of tissue heterogeneities, an anonymized voxelized phantom
derived from a prostate patient axial CT scan, see figure 1 (left), provided by La
Fe University and Polytechnic Hospital (Valencia, Spain) is selected. La Fe Hospital
routinely treats patients using LE BT permanent seed implants, corresponding this
patient to a real treatment case. This case is chosen as a benchmark test to illustrate
the performance of the algorithm because the patient showed a significant proportion
of calcifications inside the prostate. Other cases, not discussed here, have been also
analysed.
The CT provides the Hounsfield numbers (HU) in each voxel, hence, the electronic
density once a proper calibration curve is given. Unfortunately, this is not enough
information to unambiguously determine the composition of a particular voxel. As
discussed in Section 1, some assumptions have to be made to identify tissue composition.
Since we are only interested in the calcifications located inside the prostate, we
have chosen a minimal scheme: any voxel is either water-equivalent material or a
calcification. To do so, we have established an empirical threshold at 100 HU. Any
voxel with a Hounsfield number under such threshold is considered water, otherwise it
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Figure 1. Left: Axial CT scan of a benchmark patient with calcifications inside
the prostate (La Fe-Hospital), namely a particular DICOM (Digital Imaging and
Communication in Medicine) file corresponding to a transverse image plane (2.5 mm
slice thickness). Right: Tissue type segmentation (Water-blue, Calcification-white) of
the patient CT according to the calcification threshold, which is set empirically at 100
HU. Three calcifications can be observed at the center of the image.
is a calcification. This can be seen in figure 1: on the left, a CT slice, and on the right,
its material decomposition.
For the water composition, we have chosen, as recommended by the TG-43U1,
pure degassed liquid water. With respect to the calcification composition, they may
vary greatly from patient to patient. As the analysis of composition variability between
patients exceeds the scope of this paper, we have selected a typical composition: H
(5.6%), C (26.5%), N (3.6%), O (40.5%), Na (0.1%), Mg (0.2%), P (7.3%), S (0.3%)
and Ca (15.9%).
The mass density ρm of each voxel is then calculated by:
ρm =
(
ρel
ρel,w
)
× ρw × fz,m (1)
where ρel/ρel,w corresponds to the electronic density relative to water provided by the
HU calibration curve of La Fe Hospital, ρw =0.998 g/cm
3 is the water mass density in
standard conditions and fz,m = (Z/A)w/(Z/A)m is the atomic to mass number quotient
in water with respect to the medium m. fz,w = 1.0 for water, whereas for calcifications
it will depend on the prescription chosen for evaluating the average Z value. In the
present work, we have taken an effective fz,c = 0.9 value for the calcifications. With this
prescription, the calcification density will vary depending on the HU between 1.0 and
1.3 g/cm3 approximately in the region of interest, while the density of water-equivalent
prostate tissue lies between 0.85 and 1.1 g/cm3. Both the tissue type and the mass
density will be the voxel-wise input parameters for the MC dose calculations and the
analytical algorithm.
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2.2. Monte Carlo simulation
A single source model 6711-OncoSeed
TM
, manufactured by Amersham-Health, is placed
at the image center. Such source is widely used for permanent prostate implantation.
It consists of a 4.5 mm welded titanium capsule, 0.05 mm thick, with welded end caps.
The capsule contains a 3.0 mm long silver rod onto which 125I (mixture of AgBr and AgI
in a 2.5:1 molecular ratio) is deposited. Details of the geometry can be found in (Dolan
et al. 2006). With regard to this study, large variations for different source models are
not expected.
To perform the simulations, we have chosen Penelope2008 (Sempau et al. 2011,
Salvat et al. 2008), a MC code whose reliability and performance have been widely
tested (Ye et al. 2004). Penelope2008 cross section data are those of the EPDL97 (Cullen
et al. 1997) and EEDL (Cullen et al. 2001). For Compton interactions, Penelope2008
uses the impulse approximation to account for Doppler broadening and binding effects
in the photon and electron cross-sections. As a consequence, Compton cross-sections
in Penelope2008 differ from those of other MC codes. Since the 125I mean energy is
28 keV, the possible influence of such a difference is negligible as the dominating process
is photoelectric absorption. Recently, a new version of Penelope has been released.
Penelope2011 differs with respect to Penelope2008 in the improvements performed in the
description of inelastic collisions of electrons and positrons, as well as the representation
of nanometric structures. Since these features do not affect the analysis performed in
this manuscript, we have used the benchmarked routines developed for Penelope2008
and applied elsewhere (Granero et al. 2011, Vijande et al. 2012, Vijande et al. 2013).
All Monte Carlo simulations in this study conform to the recommendations of
sections V.D.2 and V.E of the TG-43U1 report (Rivard et al. 2007) and HEBD report
No. 229 (Perez-Calatayud et al. 2012). Following these guidelines, the 125I photon
spectrum in all MC simulations is taken from the current NuDat database (Kinsey
et al. 1996). For the determination of the TG-43 parameters, the source is located at the
geometric center of a spherical liquid water phantom with 40 cm radius to estimate dose
to water and simulate unbounded phantom conditions for r < 20 cm. Its composition
and mass density are those recommended by AAPM (mass density of 0.998 g/cm3 at
22 ◦C) (Rivard et al. 2007). In order to provide adequate spatial resolution, cells are:
∆r = 0.1 mm voxels for distances r ≤ 1 cm, ∆r = 0.5 mm voxels for 1 cm< r ≤ 5 cm,
∆r = 1 mm voxels for 5 cm< r ≤ 10 cm, and ∆r = 2 mm voxels for 10 cm< r ≤ 20 cm,
where r is defined as the distance from the center of the active part of the source. Angular
sampling resolution is 1◦. Additional simulations are performed as recommended by
AAPM to obtain the air kerma strength SK with the source surrounded by vacuum
except for a cylindrical air cell of size 0.1 cm× 0.1 cm at r = 10 cm.
The DICOM file containing the phantom model described in Subsection 2.1 has
been translated into Penelope2008 format using a home-made routine. Once imported,
collisional kerma using linear track-length estimator (Williamson 1987) and absorbed
dose are scored. For the case of collisional kerma, home-made routines are specifically
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developed. Both estimators are evaluated in a voxel grid taken from the DICOM
information: ∆x = ∆y = 0.977 mm and ∆z = 2.5 mm, where ∆x ×∆y corresponds to
the CT pixel size and ∆z to the CT slice thickness. Therefore, voxels have a constant
volume of 2.386 mm3. The number of photons generated in each simulation is 5 × 109,
obtaining dose uncertainties (coverage factor k = 2) about 0.01% on the prostate volume.
Due to the energy of the 125I photon spectrum, electronic equilibrium is reached even in
regions in the vicinity of the sources, hence, the dose can be approximated by collisional
kerma even for small distances from the source capsule. Therefore, in the following,
only collisional kerma will be reported.
2.3. Analytical algorithm RayStretch
We define an effective dose function that depends on the parameters of the heterogeneity
and the reference values in water, as an alternative to a computationally intensive MC
simulation on a patient basis. Thanks to our analytical algorithm, named as RayStretch,
which is based on the classic water-equivalent path length method and TG-43 reference
data, a real time dose recalculation accounting for heterogeneities in a clinical case is
expected to be feasible.
Conservation of energy We start from the law of conservation of energy: a seed imparts
on average an energy  within a volume V during its complete radioactive lifetime. If
the volume is large enough, there will be no energy leakage and the identity holds:
V (w) = V (het) (2)
where ‘w’ refers to water, that is, the homogeneous case, whereas ‘het’ refers to the
heterogeneous case, e.g. a calcification inside a water volume.
From the definition of absorbed dose D at any position ~r in a mass dM (volume
dV ) during the full source lifetime:
D(~r) =
d
dM
=⇒ d = D(~r)dM = D(~r)ρ(~r)dV (3)
where ρ(~r) is the mass density. As the energy is conserved, see equation (2), it follows:∫
V
Dw(~r)ρwdV =
∫
V
Dhet(~r)ρhet(~r)dV (4)
Note that the seed is located at the origin of the coordinate system ~rs = ~0. If
we assume a tissue with spherical symmetry, the problem depends only on the radial
coordinate r = |~r| (the distance to the seed). We rename the integral of the angular
part as
∫ 4pi
0
D(~r)dΩ ≡ 4piD(r) and obtain:∫ ∞
0
Dw(r)ρwr
2dr =
∫ ∞
0
Dhet(r)ρhet(r)r
2dr (5)
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The dose rate D˙w (dose absorbed in unit time) in the TG-43 formalism, considering
the one-dimensional, point source approximation and random orientation (Baltas
et al. 2006), is defined as:
D˙w(r) = SKΛgp,w(r)ϕan(r)
(r0
r
)2
(6)
where ϕan(r) is the anisotropy factor, Λ the dose rate constant, SK the air kerma
strength, gp,w(r) the radial dose function (dimensionless), and r0 a reference distance of
1 cm. We define D˙het analogously to the dose rate in water:
D˙het(r) = SKΛgp,het(r)ϕan(r)
(r0
r
)2
(7)
where we assume that the anisotropy factor in water ϕan,w(r) ≈ ϕan,het(r) ≡ ϕan(r) is
similar to the heterogeneous case.
We consider an exponential decay of the source’s activity with mean life τ , so that
the time dependence can be integrated independently.
D(r) =
∫ ∞
0
D˙(r)e−t/τdt = D˙(r)τ (8)
After substituting equations (6), (7) and (8) in identity (5) and cancelling constant
factors (SK, Λ, r0, τ) appearing on both sides, we obtain:
ρw
∫ ∞
0
gp,w(r)ϕan(r)dr =
∫ ∞
0
ρhet(r)gp,het(r)ϕan(r)dr (9)
This purely formal derivation is the background of our algorithm, that has to
estimate the real dose Dhet in the heterogeneous case by means of an effective radial
dose function gp,het(r).
Water equivalent path Let us assume a geometric differential segment in water ∆r. A
photon crossing a segment of the same length in another medium will not deposit the
same energy as in water. For this reason, the classic water equivalent length ∆req is
defined as a virtual segment in water, where the photon would release the same amount
of energy as in the real segment ∆r in the given medium. In general ∆req = λ∆r, where
λ is a scaling factor of the radial differential segment.
This scaling factor has to be adjusted empirically by comparing the algorithm with
the MC simulation. Nevertheless, one could relate it physically with the mass density
and the interaction cross section and parametrize it appropriately. Assuming a radial
exponential attenuation of the uncollided photons, the mean free path is given by 1/µ
(where µ is the linear attenuation coefficient). Consequently, the radial scaling factor λ
can be interpreted as the quotient between mean free paths in the corresponding media
at the mean energy value E¯ of the photon:
λ =
1/µw,E¯
1/µhet,E¯
=
µhet,E¯
µw,E¯
(10)
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One can introduce the Mass Attenuation Coefficients (Hubbell and Seltzer 2004),
where ρ is the mass density. It follows:
λ =
(µ/ρ)het,E¯
(µ/ρ)w,E¯
ρhet
ρw
(11)
Hence, the equivalent path is proportional to the relative mass density ρhet/ρw and to
the relative mass attenuation coefficients.
Energy redistribution Eqs. (2) and (9) describe the conservation of energy in the whole
volume. Nonetheless, we need to retrieve the energy deposit at each point. Thanks to
the equivalent path method, we can locally account for a greater energy deposition in
tissues with higher mass density and interaction cross section than water.
To put it another way, we transform a medium with higher density into a medium
with normal density but scaled (larger) distances, and associate the energy released
along a path in the heterogeneity to the energy released in a longer path in water
(where the dose is given by the reference values).
This is illustrated with a simple spherical tissue model, similar to an onion with
three layers:
• From r = 0 to r = a, it is water.
• From r = a to r = b, there is a calcification with a thickness t = b− a.
• For r > b, it is water.
The heterogeneity has a constant mass density ρc > ρw and higher mass attenuation
coefficient, so that λ > 1. In this scenario, we divide the region in differential steps and
assume that the energy E released between r and r + ∆r equals the energy released in
water between the equivalent path limits req and (r+∆r)eq, as depicted in figure 2. Note
that req(r ≤ a) = r, req(a < r < b) = a+λ(r−a) and req(r ≥ b) = a+λ(b−a)+(r− b).
∆req = λ∆r for a < r < b, ∆req = ∆r otherwise. Compared to equation (3), the law of
conservation of energy is applied here differentially:
Ehet
∣∣∣r+∆r
r
= Ew
∣∣∣req+∆req
req
(12)
Ew is the energy released in water and Ehet in the heterogeneous medium. The latter
is related with the integral of the radial dose function through equation (9), but in this
case restricting the infinite volume to differential integration limits:∫ r+∆r
r
ρ(r′)gp,eq(r′)ϕan(r′)dr′ = ρw
∫ req+∆req
req
gp,w(r
′)ϕan(r′)dr′ (13)
where ρ(r′) is either ρw or ρc. We also simplify the notation by changing ‘het’ with
‘eq’ (it stands for equivalent) and gp,x with gx. For small enough ∆r, the left side
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of the identity can be integrated directly and, after reorganizing terms, we obtain the
equivalent radial dose function:
geq(r) =
ρw
ρ(r)
1
∆r
∫ req+∆req
req
gw(r
′)
ϕan(r
′)
ϕan(r)
dr′ (14)
For the sake of clarity, and motivated by the small absolute variation of the
anisotropy factor with distance (Dolan et al. 2006), we assume ϕan(r
′) ≈ ϕan(req) as
constant inside the integration limits and approximate the quotient ϕan(req)/ϕan(r) ≈ 1.
Hence, the simplified version of equation 14 yields:
geq(r) =
ρw
ρ(r)
1
∆r
∫ req+∆req
req
gw(r
′)dr′ (15)
Finally, the effective dose is given by equation (7). Therefore, with this approach, the
dose is obtained from TG-43 consensus data stored on a TPS according to the radial
dose function for water gw integrated around the equivalent distance req, whereas the
anisotropy factor is not altered.
Discretization We need to adapt our equations to the voxelized phantom instead of just
a spherical three-layer tissue model. The distance r between calculation point (center
of voxel j) and source location is connected by a virtual straight line which crosses a
finite set of voxels {i}. This distance r has to be scaled according to the relative mass
density and mass attenuation coefficient of the voxels crossed by the connecting line.
For this reason, ray tracing inside the phantom is required (Siddon 1985).
Let us order spatially and numerate all intersecting voxels {i}, and denote the
corresponding segment (length of intersection) inside each voxel as ∆r(i). For each line
segment, the scaling factor of equation (11) is applied to obtain the water equivalent
voxel step ∆req(i):
∆req(i) = ∆r(i)
ρi
ρw
(µ/ρ)i
(µ/ρ)w
(16)
ρw and (µ/ρ)w are the mass density and mass attenuation coefficient in water, whereas
the subscript i refers to those quantities in voxel i. We omit the subindex E¯ for the
sake of clarity.
When adding over all intersecting voxels {i}, we obtain the global equivalent
distance:
req(r; {i}) =
∑
i
∆req(i) =
∑
i
∆r(i)
ρi
ρw
(µ/ρ)i
(µ/ρ)w
(17)
Note that for the last voxel of the ordered set (voxel j, the calculation point), the
intersection ∆rj has to be divided by two in the summation, as the segment length r
goes only until the voxel center (the middle point of the intersection of voxel with virtual
prolonged line). Idem for the first voxel intersection ∆r0 depending on the seed center
position.
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Figure 2. Schematic illustration of the redistribution of energy inside the
heterogeneity. The blue dotted line represents the construction of the equivalent dose
function geq by transforming the reference curve g (water) with the radial scaling
factor λ, see equation (11) of the algorithm. The area Ei is not directly the energy,
see equation (9), thus Ei 6= Eˆi.
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For the energy redistribution, see equation (12), we chose these lengths of
intersection ∆r(i) as differential steps. Thus, the energy Ej deposited in a certain
voxel j whose central point is separated a distance r from the radioactive seed (crossing
a set of voxels {i}) and with a last intersecting segment ∆r(j) is:
Ej
∣∣∣r+∆r(j)/2
r−∆r(j)/2
= Ew
∣∣∣req+∆req(j)/2
req−∆req(j)/2
(18)
After developing equation (18) in analogy to (15), the equivalent radial dose function
geq(r) for voxel j yields:
geq(r) =
ρw
ρj
1
∆r(j)
∫ req+∆req(j)/2
req−∆req(j)/2
gw(r
′)dr′ (19)
In summary, the calculated dose depends on the following input parameters of the
algorithm for the whole voxel set {i}:
• The voxel mass density ρi (from the CT and calibration curves).
• The voxel mass attenuation coefficient (µ/ρ)i at mean energy value E¯ (from the
CT-guided tissue segmentation and empirical calibration).
• The radial dose function in water gw(r) and anisotropy factor ϕan(r) (obtained from
TG-43 consensus data and implemented into the TPS).
• The dose rate constant Λ (obtained from TG-43 consensus data and implemented
into the TPS).
• The air kerma strength SK (TPS).
3. Results
The role played by calcifications in the dosimetric characterization of a realistic case is
depicted in figure 3 for one particular transverse image plane in the DICOM volume.
Dose rate times its distance to the source squared D˙ × |~r − ~rs|2 ≡ D˙ r2 divided by the
air kerma strength is shown in cGy mm2 h−1 U−1. Figure 3(a) shows the results of
a detailed MC simulation, whereas 3(b) depicts those obtained using RayStretch, the
algorithm proposed in Section 2.3.
The quotient between heat maps b) and a) is shown in figure 4 and compared with
the quotient between RayStretch algorithm and the TG-43 based calculation.
Three profiles are shown in figure 5 to illustrate some interesting cases. In the
image on the left of each profile, the line actually drawn across the two-dimensional
(2D) map is shown in white.
4. Discussion
In figure 3, the severe impact due to the presence of calcifications in the dosimetry as
compared with the homogeneous case can be seen. TG-43 based calculation fails to
Phys. Med. Biol. 13
Algorithm (b)
0
50
100
150
200
250
300
350
400
450
MC simulation (a)
D˙
 r 2/S
K
[cG
y m
m
2
h
-1
U
-1]
0 3(cm) 0 3(cm)
Figure 3. Dose rate by air kerma strength multiplied by the squared distance to
the radioactive seed (located at the image center) for (a) MC simulation, and (b)
analytical algorithm RayStretch. Heat maps are shown in a common color scale range
for a reliable comparison.
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Figure 4. Quotient of the dose rate calculated by the RayStretch algorithm and
the MC simulation (left), and the algorithm divided by the TG-43 based calculation
(right). Color scale is common for both maps and is adapted to the range of interest
(values outside the palette range have the same color as the closest boundary color).
incorporate any patient-related details into the dose rate map, however, both the MC
simulation and the proposed algorithm reproduce details of the anatomy by using the
information contained in the DICOM file.
In both approaches, hot spots, regions where the absorbed dose is higher than the
one predicted by TG-43, can be observed in calcificated regions and bones due to the
higher absorption coefficient of these materials. Cold spots in the form of shadows can be
seen behind calcificated regions and bones as a consequence of the attenuation suffered
when crossing the denser regions.
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Figure 5. D˙ × |~r − ~rs|2 ≡ D˙ × r2 profiles (divided by SK), where ~rs stands for the
source position. The TG-43 based calculation (blue) is compared to the RayStretch
algorithm (red) and the MC simulation (green). The insert in the top left corner of
each profile shows the line (white arrow) drawn across the 2D dose map of figure 3.
The horizontal axis refers to the local distance within the white arrow according to its
starting point and direction.
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In figure 1-left, one can identify an air-filled part of the rectum. The dose shown
in figure 3 for this volume is not correct since neither the simulation nor the analytical
algorithm include the description of air-filled volumes at this stage of the study.
Some discrepancies are observed between algorithm and simulation in figure 4-left.
In the voxels around the radioactive seed, high deviations are found as the algorithm does
not account for the source thickness. Leaving aside this local effect, the discrepancies
remain below 20% in all the regions of interest and are only evident in the cold spots.
These differences are very sensitive to the average mass absorption coefficient of equation
(11), which is empirically adjusted. Nevertheless, assuming MC as the gold standard,
the algorithm provides a much more faithful dosimetric description than the TG-43
based calculation and reduces significantly the discrepancies (figure 4-right) behind the
calcification.
This effect is clearly seen in the line profiles depicted in figure 5 for three regions
of interest which illustrate the effect on the dose produced by tissue heterogeneities:
• A: Dose cold spot caused by two prostate calcifications between seed and calculation
point.
• B and C: Dose hot spot effects in prostate calcifications.
Based on figure 5, it can be concluded that the agreement between RayStretch and
simulation is remarkable for most of the regions evaluated. A more detailed conversion
of CT to tissue composition and mass density as well as the introduction of an energy
dependent instead of average mass absorption coefficient may have the potential to
reduce the remaining deviations.
Concerning computation performance, the dose is calculated with a desktop
computer for a single seed and a grid of 61× 61× 24 = 89304 voxels, corresponding to
a cube of 6× 6× 6 cm3; the computation time is 0.14 s for the analytical algorithm (on
a single central processing unit) and 100 h for the MC simulation with 5× 109 events.
5. Conclusions
RayStretch, a simplified analytical algorithm for dose calculation in heterogeneous tissue,
is described and compared with Penelope2008 simulations for a benchmark case: an
actual prostate patient with calcifications. Simulated dose calculations are in remarkable
agreement with the analytical algorithm, which is based on the water equivalent path
length and on TG-43 consensus datasets. In addition, the algorithm is applicable for
any type of heterogeneities and has the potential for real-time computation. Due to the
current limitations of the TG-43 based calculations for low dose rate brachytherapy
during the implant, even if the agreement with simulations is not complete, any
improvement in the real-time dosimetric evaluation is welcome.
In conclusion, thanks to its compatibility with clinical TPS and its high
computation speed, RayStretch is a promising candidate for improving real-time dose
calculation and treatment quality in heterogeneous tissue during prostate implants.
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